Biohaven News - BHVN

Company Name	Stock Ticker Symbol	Market	Type
Biohaven Ltd	BHVN	NYSE	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-1.00	-2.23%	43.77	19:10:02

Open Price	Low Price	High Price	Close Price	Prev Close
44.43	42.345	45.07	43.77	44.77

more quote information »

Recent News

Date	Time	Source	Heading
4/16/2024	8:52	IHNW	FeaturedCannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix
4/13/2024	09:00	PRNUS	Biohaven Showcases Innovative Neuroscience Portfolio with 20..
2/29/2024	16:16	EDGAR2	Form 8-K - Current report
2/29/2024	16:05	PRNUS	Biohaven Reports Fourth Quarter and Full Year 2023 Financial..
1/08/2024	07:30	EDGAR2	Form 8-K - Current report
1/08/2024	07:30	PRNUS	Biohaven Highlights Progress Across Innovative Portfolio and..
1/02/2024	07:00	PRNUS	Biohaven to Present at the 42nd Annual J.P. Morgan..
12/01/2023	16:30	PRNUS	Biohaven Presents Expanded EEG and Safety Data for BHV-7000..
11/14/2023	16:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/14/2023	16:05	PRNUS	Biohaven Reports Third Quarter 2023 Financial Results and..
10/16/2023	07:00	PRNUS	Biohaven Presents Preclinical Data Demonstrating..
10/05/2023	16:05	EDGAR2	Form 8-K - Current report
10/05/2023	16:05	PRNUS	Biohaven Announces Closing of Public Offering and Full..
10/04/2023	16:05	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
10/02/2023	23:56	PRNUS	Biohaven Announces Pricing of $225 Million Public Offering..
10/02/2023	21:41	EDGAR2	Form 8-K - Current report
10/02/2023	17:09	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
10/02/2023	17:07	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
10/02/2023	16:36	PRNUS	BIOHAVEN ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES
10/02/2023	16:01	EDGAR2	Form S-3ASR - Automatic shelf registration statement of..
9/27/2023	06:58	EDGAR2	Form 8-K - Current report
9/14/2023	07:00	PRNUS	Biohaven Completes Enrollment in Pivotal Phase 3 Study of..
9/05/2023	07:00	PRNUS	Biohaven Announces Positive Data from its Exploratory..
7/31/2023	17:18	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/31/2023	16:29	EDGAR2	Form 8-K - Current report
7/31/2023	09:31	PRNUS	Biohaven's Taldefgrobep Alfa Receives EU Orphan Drug..
7/31/2023	06:59	PRNUS	Biohaven Reports Second Quarter 2023 Financial Results and..
7/28/2023	16:35	EDGAR2	Form 8-K - Current report
7/27/2023	08:42	DJN	Biohaven Told That FDA Won't Review NDA Application for..
7/27/2023	07:00	PRNUS	Biohaven Provides Preliminary EEG Data Update for Kv7..
5/31/2023	07:00	PRNUS	Biohaven Provides Overview of Clinical Progress, Regulatory..
5/25/2023	17:00	PRNUS	Biohaven to Present R&D Day at Yale School of Management
5/12/2023	16:30	PRNUS	Biohaven Reports First Quarter 2023 Financial Results and..
4/17/2023	07:00	PRNUS	Biohaven Expands Executive Leadership Team with Appointment..